UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 118

Sortiert nach

Five-year survival outcomes for patients with advanced melanoma treated with pembrolizumab in KEYNOTE-001

Annals of oncology, 2019-04, Vol.30 (4), p.582-588

2019

Link zum Volltext

Verfügbarkeit prüfen

A phase I/Ib study of concurrent intravenous (IV) and intrathecal (IT) nivolumab (Nivo) for melanoma patients (pts) with leptomeningeal disease (LMD)

Annals of oncology, 2018-10, Vol.29, p.viii464-viii464

2018

Link zum Volltext

Verfügbarkeit prüfen

Efficacy of pembrolizumab (Pembro) in patients (Pts) with advanced melanoma with stable brain metastases (BM) at baseline: A pooled retrospective analysis

Annals of oncology, 2018-10, Vol.29, p.viii444-viii444

2018

Link zum Volltext

Verfügbarkeit prüfen

Multimethod imaging, staging, and spectrum of manifestations of metastatic melanoma

Clinical radiology, 2011-03, Vol.66 (3), p.224-236

2011

Link zum Volltext

Verfügbarkeit prüfen

Pharmacokinetic/pharmacodynamic analysis of adjuvant pegylated interferon α-2b in patients with resected high-risk melanoma

Cancer chemotherapy and pharmacology, 2011-03, Vol.67 (3), p.657-666

2011

Link zum Volltext

Verfügbarkeit prüfen

Remote and Local SST Forcing in Shaping Asian-Australian Monsoon Anomalies

Journal of the Meteorological Society of Japan. Ser. II, 2005, Vol.83(2), pp.153-167

2005

Link zum Volltext

Verfügbarkeit prüfen

Follow‐up recommendations for patients with American Joint Committee on Cancer Stages I–III malignant melanoma

Cancer, 1999-12, Vol.86 (11), p.2252-2258

1999

Link zum Volltext

Verfügbarkeit prüfen

Safety of reduced infusion times for nivolumab plus ipilimumab (N + I) and nivolumab alone (N) in advanced melanoma

Annals of oncology, 2016-10, Vol.27, p.vi385-vi385

2016

Link zum Volltext

Verfügbarkeit prüfen

P0116 Updated clinical efficacy of the anti-PD-1 monoclonal antibody pembrolizumab (MK-3475) in 411 patients with melanoma

European journal of cancer (1990), 2015-07, Vol.51, p.e24-e24

2015

Link zum Volltext

Verfügbarkeit prüfen

Pembrolizumab (Pembro; Mk-3475) for Advanced Melanoma (Mel): Randomized Comparison of Two Dosing Schedules

Annals of oncology, 2014-09, Vol.25, p.v1

2014

Link zum Volltext

Verfügbarkeit prüfen

Renal cell carcinoma: A paradigm of lanthanic disease

American journal of clinical oncology, 1999-06, Vol.22 (3), p.223-231

1999

Link zum Volltext

Verfügbarkeit prüfen

Temozolomide plus thalidomide in patients with brain metastases from melanoma : A phase II study

Cancer, 2005-06, Vol.103 (12), p.2590-2597

2005

Link zum Volltext

Verfügbarkeit prüfen

Phase II Study of Temozolomide Plus Thalidomide for the Treatment of Metastatic Melanoma

Journal of clinical oncology, 2003-09, Vol.21 (17), p.3351-3356

2003

Link zum Volltext

Verfügbarkeit prüfen

Clinical results using biochemotherapy as a standard of care in advanced melanoma

Melanoma research, 2002-08, Vol.12 (4), p.381-387

2002

Link zum Volltext

Verfügbarkeit prüfen

Treatment of malignant pleural effusions with tunneled long-term drainage catheters

Journal of vascular and interventional radiology, 2001-02, Vol.12 (2), p.201

2001

Link zum Volltext

Verfügbarkeit prüfen

Treatment of metastatic melanoma in the brain with temozolomide and thalidomide

The lancet oncology, 2001-10, Vol.2 (10), p.634-635

2001

Link zum Volltext

Verfügbarkeit prüfen

New approaches in the treatment of metastatic melanoma: thalidomide and temozolomide

Oncology (Williston Park, N.Y.), 2000-12, Vol.14 (12 Suppl 13), p.25

Hwu, W J

2000

Link zum Volltext

Verfügbarkeit prüfen

A phase II trial comparing five dose levels of BEC2 anti-idiotypic monoclonal antibody vaccine that mimics GD3 ganglioside

Vaccine, 2004-07, Vol.22 (21), p.2904-2909

2004

Link zum Volltext

Verfügbarkeit prüfen

Temozolomide Plus Thalidomide in Patients With Advanced Melanoma: Results of a Dose-Finding Trial

Journal of clinical oncology, 2002-06, Vol.20 (11), p.2610-2615

2002

Link zum Volltext

Verfügbarkeit prüfen

Systemic chemotherapy

Clinics in plastic surgery, 2000-07, Vol.27 (3), p.451

2000

Link zum Volltext

Verfügbarkeit prüfen

1139P Long-term safety profile of pembrolizumab monotherapy and relationship with clinical outcome: A pooled analysis of patients with advanced melanoma

Annals of oncology, 2020-09, Vol.31, p.S762-S763

2020

Link zum Volltext

Verfügbarkeit prüfen

A clinical-pharmacological evaluation of percutaneous isolated hepatic infusion of doxorubicin in patients with unresectable liver tumors

Oncology research, 1999, Vol.11 (11-12), p.529

1999

Link zum Volltext

Verfügbarkeit prüfen

A Phase 1/2 trial of intratumoral (i.t.) IMO-2125 (IMO) in combination with checkpoint inhibitors (CPI) in PD-(L)1-refractory melanoma

Annals of oncology, 2017-09, Vol.28, p.v421-v421

2017

Link zum Volltext

Verfügbarkeit prüfen

The safety of temozolomide in the treatment of malignancies

Expert opinion on drug safety, 2009-07, Vol.8 (4), p.493-499

2009

Link zum Volltext

Verfügbarkeit prüfen

KEYNOTE 029: Phase 1/2 randomized study of pembrolizumab (pembro) plus 2 dose regimens of ipilimumab (ipi) for advanced melanoma

Annals of oncology, 2017-09, Vol.28, p.v446-v446

2017

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 118

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieInvestigational New Drugs

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(104)
Mit Volltextzugriff
(103)

Publikationsform

Artikel
(112)
Tagungsberichte
(6)

Sprache

Englisch
(118)
Japanisch
(14)

Erscheinungsjahr

n.n

Thema

Science & Technology
(79)
Humans
(66)
Life Sciences & Biomedicine
(55)
Male
(46)
Female
(45)
Biological And Medical Sciences
(36)
Medical Sciences
(33)
Adult
(32)
Middle Aged
(30)
Schizophrenia
(24)
Oncology
(20)
Psychiatry
(18)
Schizophrenia - Genetics
(18)
Aged
(16)
Technology
(15)
Psychology. Psychoanalysis. Psychiatry
(14)
Adolescent
(13)
Melanoma - Pathology
(13)
Psychopathology. Psychiatry
(13)
Adult And Adolescent Clinical Studies
(11)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Five-year survival outcomes for patients with advanced melanoma treated with pembrolizumab in KEYNOTE-001

A phase I/Ib study of concurrent intravenous (IV) and intrathecal (IT) nivolumab (Nivo) for melanoma patients (pts) with leptomeningeal disease (LMD)

Efficacy of pembrolizumab (Pembro) in patients (Pts) with advanced melanoma with stable brain metastases (BM) at baseline: A pooled retrospective analysis

Multimethod imaging, staging, and spectrum of manifestations of metastatic melanoma

Pharmacokinetic/pharmacodynamic analysis of adjuvant pegylated interferon α-2b in patients with resected high-risk melanoma

Remote and Local SST Forcing in Shaping Asian-Australian Monsoon Anomalies

Follow‐up recommendations for patients with American Joint Committee on Cancer Stages I–III malignant melanoma

Safety of reduced infusion times for nivolumab plus ipilimumab (N + I) and nivolumab alone (N) in advanced melanoma

P0116 Updated clinical efficacy of the anti-PD-1 monoclonal antibody pembrolizumab (MK-3475) in 411 patients with melanoma

Pembrolizumab (Pembro; Mk-3475) for Advanced Melanoma (Mel): Randomized Comparison of Two Dosing Schedules

Renal cell carcinoma: A paradigm of lanthanic disease

Temozolomide plus thalidomide in patients with brain metastases from melanoma : A phase II study

Phase II Study of Temozolomide Plus Thalidomide for the Treatment of Metastatic Melanoma

Clinical results using biochemotherapy as a standard of care in advanced melanoma

Treatment of malignant pleural effusions with tunneled long-term drainage catheters

Treatment of metastatic melanoma in the brain with temozolomide and thalidomide

New approaches in the treatment of metastatic melanoma: thalidomide and temozolomide

A phase II trial comparing five dose levels of BEC2 anti-idiotypic monoclonal antibody vaccine that mimics GD3 ganglioside

Temozolomide Plus Thalidomide in Patients With Advanced Melanoma: Results of a Dose-Finding Trial

Systemic chemotherapy

1139P Long-term safety profile of pembrolizumab monotherapy and relationship with clinical outcome: A pooled analysis of patients with advanced melanoma

A clinical-pharmacological evaluation of percutaneous isolated hepatic infusion of doxorubicin in patients with unresectable liver tumors

A Phase 1/2 trial of intratumoral (i.t.) IMO-2125 (IMO) in combination with checkpoint inhibitors (CPI) in PD-(L)1-refractory melanoma

The safety of temozolomide in the treatment of malignancies

KEYNOTE 029: Phase 1/2 randomized study of pembrolizumab (pembro) plus 2 dose regimens of ipilimumab (ipi) for advanced melanoma

Aktive Filter

Suchergebnisse filtern